Valuation AstraZeneca PLC

Stocks

Market Closed - London S.E. Other stock markets 11:35:15 2026-07-15 EDT			5-day change	1st Jan Change
12,566.00 ^GBX	+1.63%		-11.76%	-8.88%

07-15	ASTRAZENECA : Deutsche Bank reiterates its Sell rating	ZD
07-15	Innovent Biologics Shares Surge on Spero Deal That Could Be Worth $1.1 Billion	DJ

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	262,883	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-8.66%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	282,080	274,828	266,440
Change	-	12.57%	-0.25%	-1.74%	36.64%	-9.35%	-2.57%	-3.05%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21.2x	18.6x	16.1x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.96x	4.31x	3.64x
PEG	-	0x	0.4x	1.6x	0.6x	0.9x	1.3x	1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.16x	3.94x	3.69x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.46x	4.11x	3.74x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.3x	11x	9.72x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.3x	11.7x	10.4x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	28.1x	20.8x	18.2x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.56%	4.81%	5.49%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.341	3.522	3.657
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.97%	2.08%	2.16%
EPS ²	0.08	2.11	3.81	4.5	6.54	8.007	9.124	10.55
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	41.7%	38.6%	34.7%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,216	66,797	71,159
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,854	24,928	27,403
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,136	23,396	25,713
Net income ¹	112	3,288	5,961	7,035	10,225	12,432	13,937	15,996
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,197	11,945	3,556
Reference price ²	117.51	135.16	135.02	131.05	185.60	169.49	169.49	169.49
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTRAZENECA PLC	20.69x	4.37x	12.08x	2.02%	257B
ELI LILLY AND COMPANY	34.25x	12.25x	25.43x	0.59%	1,028B
JOHNSON & JOHNSON	27.09x	6.22x	16.9x	2.1%	611B
ABBVIE INC.	30.33x	7.27x	14.9x	2.81%	432B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	323B
NOVARTIS AG	21.17x	5.44x	13.17x	2.9%	277B
NOVO NORDISK A/S	13.99x	5.26x	10.84x	3.55%	217B
AMGEN INC.	23.3x	6.19x	10.94x	2.84%	192B
GILEAD SCIENCES, INC.	-46.85x	5.61x	31x	2.5%	161B
PFIZER INC.	12.32x	3.04x	7.69x	7.12%	138B
Average	15.38x	6.00x	15.36x	2.95%	363.65B
Weighted average by Cap.	22.92x	7.49x	17.50x	2.23%